(Q33956442)

30 July 2017

title

Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario (English)

1 reference

enzyme replacement therapy

30 July 2017

main subject

0 references

1 reference

Clarke JT

1

1 reference

30 July 2017

Amato D

series ordinal

2

1 reference

30 July 2017

Deber RB

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Canadian Medical Association Journal

30 July 2017

published in

1 reference

30 July 2017

volume

165

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

595-596

1 reference

Measurement of health state utilities for economic appraisal

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

Alglucerase. A pharmacoeconomic appraisal of its use in the treatment of Gaucher's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

Guidelines for economic analysis of pharmaceutical products: a draft document for Ontario and Canada

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

Enzyme replacement therapy for Gaucher's disease: the early Canadian experience

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

A general health policy model: update and applications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

Translating Technology Assessment Into Policy: Conceptual Issues and Tough Choices

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

Alglucerase. A review of its therapeutic use in Gaucher's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=81418

Bentham in a box: technology assessment and health care allocation

5 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11563212

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Alglucerase for Gaucher's disease: dose, costs and benefits

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11563212

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11563212

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMC publication ID

81418

1 reference

30 July 2017

1 reference